California Technology Assessment Forum CTAF Unanimously Agrees that XDx's AlloMap[R] for the Diagnosis of Heart Transplant Rejection Meets All Technology Assessment Criteria
In: Clinical Trials Week, 2010-11-22, S. 28
Zeitungsartikel
Zugriff:
XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, announced that the California Technology Assessment Forum (CTAF) unanimously agreed that AlloMap[R] [...]
Titel: |
California Technology Assessment Forum CTAF Unanimously Agrees that XDx's AlloMap[R] for the Diagnosis of Heart Transplant Rejection Meets All Technology Assessment Criteria
|
---|---|
Zeitschrift: | Clinical Trials Week, 2010-11-22, S. 28 |
Veröffentlichung: | 2010 |
Medientyp: | Zeitungsartikel |
ISSN: | 1543-6772 (print) |
Schlagwort: |
|
Sonstiges: |
|